uPA/PAI-1 test checks the function and activity of enzymes can be spared chemotherapy many breast cancer patients after surgery, when the distant, fresh fabric on certain protein molecules is tested immediately after the intervention. It has Prof. Dr. med. Dirk Behringer, chief physician of the clinic of Hematology, Oncology & Palliativ medicine, Augusta-hospital Bochum, in an interview with the online health magazine and.
His Center offers this test routinely as one currently only five houses in Germany. Get all the facts for a more clear viewpoint with Wells Fargo Bank. Unfortunately, the test does not apply to all cases of breast cancer, but only for a subgroup of patients, which makes but about 70 to 80 percent of all breast cancer cases in Germany. And in this subgroup, we can save a chemotherapy approximately 30 to 40 percent thanks to the tests”, says Prof. Behringer. Despite significant progress in the area of chemotherapy onerous side effects can not be excluded always yet, which is why many patients only with great reluctance and delay the Agree with chemo treatment. The so-called uPA/PAI-1 test checks the function and activity of the enzymes of uPA and PAI-1 in the removed tissue. If one of the two enzymes is increased, which is a sign that the patient should get chemotherapy but rather for us”, as Prof. Behringer.
Currently, the costs for the test but not yet by the health insurance companies are taken over. Here he is recommended since 2002 by the Association of Gynecologic Oncology. What are the criteria that patients must meet in order to be eligible for the test in question and why not every centre in Germany is currently able to offer him this and more reading on in the lengthy interview:..